Agilent Technologies announced earlier this month that it has acquired 20 acres in Weld County, Colorado, which it plans to use to build a new pharmaceutical manufacturing facility. The addition of this facility, which will be located in Frederick, Colorado, will more than double Agilent’s commercial manufacturing capacity for nucleic acid active pharmaceutical ingredients. According to Skip Thune, General Manager of Agilent’s Nucleic Acids Solutions Division, “The products manufactured at this site will be used by our customers to improve the lives of patients suffering from a variety of diseases. At Agilent, we are committed...
Read more